Reprogramming to a muscle fate by fusion recapitulates differentiation

Journal of Cell Science

Volumn 122, Issue 7, 2009, Pages 1045-1053

  Pomerantz, Jason H ^a,b   Mukherjee, Semanti ^a,c   Palermo, Adam T ^a,d   Blau, Helen M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d GENZYME CORPORATION   (United States)

Author keywords

Fusion; Heterokaryon; Histone deacetylation; MyoD; Reprogramming

Indexed keywords

HISTONE DEACETYLASE; MYOD PROTEIN; ENZYME INHIBITOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CELL STRAIN HEPG2; CELL TYPE; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; EXCITATION CONTRACTION COUPLING; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HETEROKARYON; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL LINEAGE; CYTOLOGY; DNA MICROARRAY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KERATINOCYTE; METABOLISM; MUSCLE; MYOBLAST; SPECIES DIFFERENCE; TUMOR CELL LINE;

MAMMALIA;

ANIMALS; CELL DIFFERENTIATION; CELL FUSION; CELL LINE, TUMOR; CELL LINEAGE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HUMANS; KERATINOCYTES; MICE; MUSCLES; MYOBLASTS; MYOD PROTEIN; NUCLEAR REPROGRAMMING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SPECIES SPECIFICITY;

EID: 66849132244     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.041376     Document Type: Article

References (41)

1. Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., Chiba, T. and Yamanaka, S. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699-702.
2. Blakely, B. T. (1993). Negative and positive regulatory mechanisms in muscle and liver differentiation. PhD Thesis, Stanford University, Palo Alto, CA, USA.
3. Blau, H. M., Chiu, C. P. and Webster, C. (1983). Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32, 1171-1180.
4. Blau, H. M., Chiu, C. P., Pavlath, G. K. and Webster, C. (1985a). Muscle gene expression in heterokaryons. Adv. Exp. Med. Biol. 182, 231-247.
5. Blau, H. M., Pavlath, G. K., Hardeman, E. C., Chiu, C. P., Silberstein, L., Webster, S. G., Miller, S. C. and Webster, C. (1985b). Plasticity of the differentiated state. Science 230, 758-766.
6. Chiu, C. P. and Blau, H. M. (1984). Reprogramming cell differentiation in the absence of DNA synthesis. Cell 37, 879-887.
7. Choi, J., Costa, M. L., Mermelstein, C. S., Chagas, C., Holtzer, S. and Holtzer, H. (1990). MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc. Natl. Acad. Sci. USA 87, 7988-7992.
8. Cowan, C. A., Atienza, J., Melton, D. A. and Eggan, K. (2005). Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309, 1369-1373.
9. Davis, R. L., Cheng, P. F., Lassar, A. B. and Weintraub, H. (1990). The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60, 733-746.
10. Ding, X., Wang, Y., Zhang, D., Wang, Y., Guo, Z. and Zhang, Y. (2008). Increased pre-implantation development of cloned bovine embryos treated with 5-aza-2′-deoxycytidine and trichostatin A. Theriogenology 70, 622-630.
11. Gurdon, J. B. and Byrne, J. A. (2003). The first half-century of nuclear transplantation. Proc. Natl. Acad. Sci. USA 100, 8048-8052.
12. Hanna, J., Wernig, M., Markoulaki, S., Sun, C. W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L. C., Townes, T. M. et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923.
13. Hess-Stumpp, H., Bracker, T. U., Henderson, D. and Politz, O. (2007). MS-275, a potent orally available inhibitor of histone deacetylases-the development of an anticancer agent. Int. J. Biochem. Cell Biol. 39, 1388-1405.
14. Higgs, D. R. (2008). A new dawn for stem-cell therapy. N. Engl. J. Med. 358, 964-966.
15. Hochedlinger, K. and Jaenisch, R. (2002). Nuclear transplantation: lessons from frogs and mice. Curr. Opin. Cell Biol. 14, 741-748.
16. Hong, F., Breitling, R., McEntee, C. W., Wittner, B. S., Nemhauser, J. L. and Chory, J. (2006). RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22, 2825-2827.
17. Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E. and Melton, D. A. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26, 795-797.
18. Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A. and Vingron, M. (2002). Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 Suppl. 1, S96-S104.
19. Iager, A. E., Ragina, N. P., Ross, P. J., Beyhan, Z., Cunniff, K., Rodriguez, R. M. and Cibelli, J. B. (2008). Trichostatin A improves histone acetylation in bovine somatic cell nuclear transfer early embryos. Cloning Stem Cells 10, 371-379.
20. Iezzi, S., Cossu, G., Nervi, C., Sartorelli, V. and Puri, P. L. (2002). Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. Proc. Natl. Acad. Sci. USA 99, 7757-7762.
21. Jaenisch, R. and Young, R. (2008). Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582.
22. Johansson, C. B., Youssef, S., Koleckar, K., Holbrook, C., Doyonnas, R., Corbel, S. Y., Steinman, L., Rossi, F. M. and Blau, H. M. (2008). Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat. Cell Biol. 10, 575-583.
23. Kassar-Duchossoy, L., Gayraud-Morel, B., Gomes, D., Rocancourt, D., Buckingham, M., Shinin, V. and Tajbakhsh, S. (2004). Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature 431, 466-471.
24. Kawahigashi, H., Harada, Y., Asano, A. and Nakamura, M. (1998). A cis-acting regulatory element that affects the alternative splicing of a muscle-specific exon in the mouse NCAM gene. Biochim. Biophys. Acta 1397, 305-315.
25. Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S. and Meissner, A. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55.
26. Pavlath, G. K. and Blau, H. M. (1986). Expression of muscle genes in heterokaryons depends on gene dosage. J. Cell Biol. 102, 124-130.
27. Piekarz, R. and Bates, S. (2004). A review of depsipeptide and other histone deacetylase inhibitors in clinical trials. Curr. Pharm. Des. 10, 2289-2298.
28. Pralong, D., Trounson, A. O. and Verma, P. J. (2006). Cell fusion for reprogramming pluripotency: toward elimination of the pluripotent genome. Stem Cell Rev. 2, 331-340.
29. Ringertz, N., Savage, R. E. (1976). Cell Hybrids. New York: Academic Press.
30. Rudnicki, M. A. and Jaenisch, R. (1995). The MyoD family of transcription factors and skeletal myogenesis. BioEssays 17, 203-209.
31. Schafer, B. W., Blakely, B. T., Darlington, G. J. and Blau, H. M. (1990). Effect of cell history on response to helix-loop-helix family of myogenic regulators. Nature 344, 454-458.
32. Shi, L. H., Miao, Y. L., Ouyang, Y. C., Huang, J. C., Lei, Z. L., Yang, J. W., Han, Z. M., Song, X. F., Sun, Q. Y. and Chen, D. Y. (2008). Trichostatin A (TSA) improves the development of rabbit-rabbit intraspecies cloned embryos, but not rabbit-human interspecies cloned embryos. Dev. Dyn. 237, 640-648.
33. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
34. Tapscott, S. J., Davis, R. L., Thayer, M. J., Cheng, P. F., Weintraub, H. and Lassar, A. B. (1988). MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242, 405-411.
35. Terranova, R., Pereira, C. F., Du, Roure, C., Merkenschlager, M. and Fisher, A. G. (2006). Acquisition and extinction of gene expression programs are separable events in heterokaryon reprogramming. J. Cell Sci. 119, 2065-2072.
36. Venuti, J. M., Morris, J. H., Vivian, J. L., Olson, E. N. and Klein, W. H. (1995). Myogenin is required for late but not early aspects of myogenesis during mouse development. J. Cell Biol. 128, 563-576.
37. Weimann, J. M., Johansson, C. B., Trejo, A. and Blau, H. M. (2003). Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat. Cell Biol. 5, 959-966.
38. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E. and Jaenisch, R. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324.
39. Wright, W. E. (1984). Induction of muscle genes in neural cells. J. Cell Biol. 98, 427-435.
40. Yun, K. and Wold, B. (1996). Skeletal muscle determination and differentiation: story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8, 877-889.
41. Zhang, F., Pomerantz, J. H., Sen, G., Palermo, A. T. and Blau, H. M. (2007). Active tissue-specific DNA demethylation conferred by somatic cell nuclei in stable heterokaryons. Proc. Natl. Acad. Sci. USA 104, 4395-4400.